Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure
- 1 August 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (5) , 46-52
- https://doi.org/10.1016/0002-9149(87)90525-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Inotropic Drugs for the Treatment of Heart FailureThe Journal of Clinical Pharmacology, 1985
- Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failureAmerican Heart Journal, 1985
- Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patientsJournal of the American College of Cardiology, 1984
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performanceThe American Journal of Cardiology, 1984
- Hemodynamic Effects of MDL 17,043, a New Cardiotonic Agent, in Patients with Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1983
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3-Dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)Journal of Cardiovascular Pharmacology, 1982
- Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043Journal of Cardiovascular Pharmacology, 1982
- Cardiovascular Properties of a New Cardiotonic AgentJournal of Cardiovascular Pharmacology, 1982